Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
BACKGROUND:The World Health Organization recommends annual mass azithromycin administration in communities with at least 10% prevalence of trachomatous inflammation-follicular (TF) in children, with further treatment depending on reassessment after 3-5 years. However, the effect of stopping mass azi...
Main Authors: | Jeremy D Keenan, Zerihun Tadesse, Sintayehu Gebresillasie, Ayalew Shiferaw, Mulat Zerihun, Paul M Emerson, Kelly Callahan, Sun Y Cotter, Nicole E Stoller, Travis C Porco, Catherine E Oldenburg, Thomas M Lietman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-08-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC6091918?pdf=render |
Similar Items
-
Linear growth in preschool children treated with mass azithromycin distributions for trachoma: A cluster-randomized trial.
by: Jeremy D Keenan, et al.
Published: (2019-06-01) -
The population-based prevalence of trachomatous scarring in a trachoma hyperendemic setting: results from 152 impact surveys in Amhara, Ethiopia
by: Tigist Astale, et al.
Published: (2021-05-01) -
Ocular Chlamydia trachomatis infection and infectious load among pre-school aged children within trachoma hyperendemic districts receiving the SAFE strategy, Amhara region, Ethiopia.
by: Scott D Nash, et al.
Published: (2020-05-01) -
Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
by: Abdou Amza, et al.
Published: (2021-01-01) -
A randomized trial of two coverage targets for mass treatment with azithromycin for trachoma.
by: Sheila K West, et al.
Published: (2013-01-01)